Literature DB >> 16027189

Efficacy of Ovsynch program on reproductive performance in dairy cattle: a meta-analysis.

A R Rabiee1, I J Lean, M A Stevenson.   

Abstract

The efficacy of the Ovsynch program in improving conception and pregnancy rates was compared with untreated controls and other synchrony programs in lactating dairy cows. This meta-analysis examined 71 treatment and control comparisons extracted from 53 research papers. Programs evaluated included Ovsynch, natural breeding, single, double, or triple prostaglandin injections, Select Synch, Heat Synch, and modified Ovsynch. Pregnancy rates for Ovsynch programs did not differ significantly from those with natural breeding programs [predicted Bayesian relative risk (RR) = 1.04, 95% Bayesian credible interval = 0.36 to 3.23]. Results of Ovsynch vs. PGF(2alpha) programs showed that the risk of conception (predicted Bayesian RR = 0.89, 95% Bayesian credible interval = 0.31 to 2.64), and pregnancy rates predicted Bayesian RR = 1.11, 95% Bayesian credible interval = 0.61 to 2.13) did not differ significantly between the Ovsynch group and cows in the PGF(2alpha) group. Comparisons between Ovsynch and Select Synch demonstrated that the risk of conception (predicted Bayesian RR = 0.94, 95% Bayesian credible interval = 0.52 to 1.59), and pregnancy rates (predicted Bayesian RR = 1.08, 95% Bayesian credible interval = 0.38 to 3.09) did not differ significantly between the 2 groups. Examination of Ovsynch vs. modified Ovsynch programs showed that the risk of pregnancy in cows synchronized with modified Ovsynch was similar to those treated with Ovsynch (predicted Bayesian RR = 0.89, 95% Bayesian credible interval = 0.71 to 1.12).Meta-analyses identified that the conception and pregnancy rates obtained with the prostaglandin, Select Synch, and modified Ovsynch (including presynch and CoSynch) programs were comparable with the Ovsynch program. Modifications to the Ovsynch program such as presynchronization and timed artificial insemination at the time of second GnRH injection (CoSynch) may be an alternative for reproductive management of dairy herds where detection of estrus is less than optimal. The findings of this study demonstrate that the Ovsynch program could benefit dairy operations because it allows for timed artificial insemination of lactating cows without detection of estrus. There was, however, little or no significant improvement in pregnancy rates using Ovsynch over other programs and the costs of labor and hormone administration should be considered when selecting this form of reproductive technology for routine use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027189     DOI: 10.3168/jds.S0022-0302(05)72955-6

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  5 in total

1.  Effect of timing of artificial insemination after synchronization of ovulation on reproductive performance in Holstein dairy cows.

Authors:  Tahir Bayril; Orhan Yilmaz
Journal:  Trop Anim Health Prod       Date:  2012-07-22       Impact factor: 1.559

2.  Resynchronisation as an Element of Improving Cattle Reproduction Efficiency.

Authors:  Jędrzej M Jaśkowski; Marek Gehrke; Magdalena Herudzińska; Bartłomiej M Jaśkowski; Klaus-Peter Brüssow
Journal:  J Vet Res       Date:  2019-03-22       Impact factor: 1.744

3.  Clinical prospects proposing an increase in the luteolytic dose of prostaglandin F in dairy cattle.

Authors:  Fernando LÓpez-Gatius
Journal:  J Reprod Dev       Date:  2020-11-09       Impact factor: 2.214

Review 4.  Ovarian response to prostaglandin F in lactating dairy cows: A clinical update.

Authors:  Fernando López-Gatius
Journal:  J Reprod Dev       Date:  2021-12-30       Impact factor: 2.214

5.  Effect of post artificial insemination treatment with two different progesterone intravaginal devices on conception and synchronization of the returning estrus in Japanese Black cows.

Authors:  Naoki Yamamoto; Ryo Nishimura; Yosuke Gunji; Makoto Saneshige; Kensuke Kiriki; Mitsugu Hishinuma
Journal:  J Vet Med Sci       Date:  2018-10-18       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.